News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Captura de pantalla: Universidad Estatal de Ball]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/05134947/p-1-91536310-quick-hit-hugh-jackmans-advice-for-new-grads-follow-your-heart.webp)
![[Imagen: cortesía de Abrams Books]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/05131147/p-1-91536171-chip-kidd.webp)
![[Imagen: Jakub Porzycki/NurPhoto vía Getty Images]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/05100147/p-1-91529322-stop-letting-chatgpt-ai-chatbots-train-on-your-data-anthropic-claude-perplexity-google-gemini-opt-out.webp)
![[Imagen: LIGHTFIELD STUDIOS/Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/04145816/p-1-91534847-how-to-show-up-at-work-when-your-life-is-falling-apart-e1777928350433.webp)
